Capillary morphogenesis protein-2 is the major receptor mediating lethality of anthrax toxin in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 30, 2009, Pages 12424-12429

  Liu, Shihui ^a   Crown, Devorah ^a   Miller Randolph, Sharmina ^a   Moayeri, Mahtab ^a   Wang, Hailun ^a   Hu, Haijing ^a   Morley, Thomas ^a   Leppla, Stephen H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Edema toxin; Lethal toxin; Tumor endothelium marker 8

Indexed keywords

ANTHRAX TOXIN; CAPILLARY MORPHOGENESIS PROTEIN 2; ENDOSIALIN; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; CONTROLLED STUDY; DEVELOPMENT; FEMALE; GENE DELETION; IN VIVO STUDY; LETHALITY; LIFE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REPRODUCTION;

ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACILLUS ANTHRACIS; BACTERIAL TOXINS; BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENES, ESSENTIAL; HOST-PATHOGEN INTERACTIONS; MALE; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; RECEPTORS, PEPTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPORES, BACTERIAL;

BACILLUS ANTHRACIS; MUS;

EID: 68149175255     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0905409106     Document Type: Article

References (32)

1. Cui X, et al. (2005) Late treatment with a protective antigen-directed monoclonal antibody improves hemodynamic function and survival in a lethal toxin-infused rat model of anthrax sepsis. J Infect Dis 191:422-434.
2. Liu S, Schubert RL, Bugge TH, Leppla SH (2003) Anthrax toxin: Structures, functions and tumour targeting. Expert Opin Biol Ther 3:843-853.
3. Leppla SH (2006) Bacillus anthracis toxins. The Comprehensive Sourcebook of Bacterial Protein Toxins. eds Alouf JE, Popoff MR (Academic, Burlington, MA), pp 323-347.
4. Young JA, Collier RJ 2007. Anthrax toxin: Receptor-binding, internalization, pore formation, and translocation. Annu Rev Biochem 76:243-265.
5. Bradley KA, Mogridge J, Mourez M, Collier RJ, Young JA (2001) Identification of the cellular receptor for anthrax toxin. Nature 414:225-229.
6. Scobie HM, Rainey GJ, Bradley KA, Young JA (2003) Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc Natl Acad Sci USA 100:5170-5174.
7. Wei W, Lu Q, Chaudry GJ, Leppla SH, Cohen SN (2006) The LDL receptor-related protein LRP6 mediates internalization and lethality of anthrax toxin. Cell 124:1141-1154.
8. Abrami L, et al. (2008) Functional interactions between anthrax toxin receptors and the WNT signalling protein LRP6. Cell Microbiol 10:2509-2519.
9. Leppla SH (1982) Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proc Natl Acad Sci USA 79:3162-3166.
10. Firoved AM, et al. (2005) Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice. Am J Pathol 167:1309-1320.
11. Duesbery NS, et al. (1998) Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor. Science 280:734-737.
12. Vitale G, et al. (1998) Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine/threonine phosphorylation of MAPKs in cultured macrophages. Biochem Biophys Res Commun 248:706-711.
13. Vitale G, Bernardi L, Napolitani G, Mock M, Montecucco C (2000) Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor. Biochem J 352 Pt 3:739-745.
14. Baldari CT, Tonello F, Paccani SR, Montecucco C (2006) Anthrax toxins: A paradigm of bacterial immune suppression. Trends Immunol 27:434-440.
15. Moayeri M, Haines D, Young HA, Leppla SH (2003) Bacillus anthracis lethal toxin induces TNF-á-independent hypoxia-mediated toxicity in mice. J Clin Invest 112:670-682.
16. Cui X, et al. (2004) Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am J Physiol 286:R699-R709.
17. Abrami L, Leppla SH, van der Goot FG (2006) Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis. J Cell Biol 172:309-320.
18. St Croix B, et al. (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202.
19. Dowling O, et al. (2003) Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 73:957-966.
20. Hanks S, et al. (2003) Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Am J Hum Genet 73:791-800.
21. Scobie HM, et al. (2006) Anthrax toxin receptor 2-dependent lethal toxin killing in vivo. PLoS Pathog 2:e111.
22. Liu S, Leppla SH (2003) Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J Biol Chem 278:5227-5234.
23. Liu S, Leung HJ, Leppla SH (2007) Characterization of the interaction between anthrax toxin and its cellular receptors. Cell Microbiol 9:977-987.
24. Arora N, Leppla SH (1993) Residues 1-254 of anthrax toxin lethal factor are sufficient to cause cellular uptake of fused polypeptides. J Biol Chem 268:3334-3341.
25. Rainey GJ, et al. (2005) Receptor-specific requirements for anthrax toxin delivery into cells. Proc Natl Acad Sci USA 102:13278-13283.
26. Rosovitz MJ, et al. (2003) Alanine scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody. J Biol Chem 278:30936-30944.
27. Pezard C, Berche P, Mock M (1991) Contribution of individual toxin components to virulence of Bacillus anthracis. Infect Immun 59:3472-3477.
28. Varughese M, Teixeira AV, Liu S, Leppla SH (1999) Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Infect Immun 67:1860-1865.
29. Molin FD, et al. (2008) Ratio of lethal and edema factors in rabbit systemic anthrax. Toxicon 52:824-828.
30. Nagy A, Gertsenstein M, Vintersten K, Behringer RR (2003) Manipulating the Mouse Embryo: A Laboratory Manual (Cold Spring Harbor Lab Press. Cold Spring Harbor, NY).
31. Pomerantsev AP, Sitaraman R, Galloway CR, Kivovich V, Leppla SH (2006) Genome engineering in Bacillus anthracis using Cre recombinase. Infect Immun 74:682-693.
32. Hu H, Sa Q, Koehler TM, Aronson AI, Zhou D (2006) Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell Microbiol 8:1634-1642.